c
h
p
e
r
ticularli
dirofi
lariasi
hypersensit
reaction
infl
ammat
neoplasia
basophil
leukemia
mast
cell
tumormastocytosi
lymphomatoid
granulomatosi
essenti
thrombocythemia
drug
reaction
heparin
penicillin
e
decreas
number
leukocyt
denot
addit
suffi
x
penia
cytopenia
neutropenia
defi
ned
absolut
neutrophil
count
dog
cat
lymphopenia
defi
ned
absolut
lymphocyt
count
dog
cat
clinic
import
eosinopenia
basopenia
diffi
cult
defi
ne
lower
limit
normal
dog
cat
typic
extend
eosinopenia
may
occur
acut
infl
ammat
infect
b
eosinopenia
also
may
follow
endogen
corticosteroid
releas
secondari
stress
trauma
hyperadrenocortic
may
associ
exogen
corticosteroid
adrenocorticotrop
hormon
acth
administr
iv
assess
wbc
morpholog
extrem
import
alter
wbc
morpholog
presenc
cytoplasm
inclus
import
indic
physiolog
abnorm
diseas
tabl
b
abnorm
morpholog
alway
indic
abnorm
compromis
cell
function
normal
morpholog
guarante
normal
cell
function
c
characterist
cyclic
pattern
chang
wbc
number
time
uniqu
certain
disord
eg
canin
cyclic
hematopoiesi
neutrophil
peripher
blood
randomli
dispers
two
interchang
populationsth
circul
margin
pool
ii
circul
pool
includ
neutrophil
locat
within
vasculatur
sampl
routin
blood
collect
quantifi
ed
cbc
iii
margin
pool
compos
neutrophil
loos
attach
capillari
venul
endotheli
surfac
complet
blood
count
cbc
evalu
white
blood
cell
wbc
leukocyt
red
blood
cell
rbc
erythrocyt
platelet
ii
leukogram
compos
total
rel
absolut
differenti
leukocyt
count
morpholog
evalu
absolut
differenti
leukocyt
count
total
wbc
wbc
type
rel
percent
prefer
evalu
method
result
fewer
interpret
error
b
canin
felin
leukocyt
present
follow
numer
order
preval
healthi
anim
neutrophil
lymphocyt
monocyt
eosinophil
basophil
iii
publish
total
leukocyt
count
health
dog
cat
mahaffey
number
provid
guidelin
use
refer
rang
provid
laboratori
interpret
leukogram
b
interpret
leukogram
base
absolut
leukocyt
count
report
numbersml
rather
rel
percentag
c
absolut
number
variou
wbc
alter
physiolog
patholog
pharmacolog
process
increas
number
leukocyt
denot
addit
suffi
x
ilia
osi
neutrophilia
defi
ned
absolut
neutrophil
count
dog
cat
common
contributor
leukocytosi
monocytosi
defi
ned
absolut
monocyt
count
dog
cat
lymphocytosi
defi
ned
absolut
lymphocyt
count
dog
cat
eosinophilia
defi
ned
absolut
eosinophil
count
dog
cat
gener
occur
hypersensit
reaction
parasit
infect
basophilia
defi
ned
absolut
basophil
count
dog
cat
basophilia
rare
often
accompani
eosinophilia
associ
parasit
diseas
par
therefor
sampl
blood
collect
procedur
neutrophil
product
matur
occur
bone
marrow
precursor
progress
stage
myeloblast
progranulocyt
myelocyt
metamyelocyt
band
neutrophil
matur
segment
neutrophil
ii
neutrophil
precursor
divid
two
pool
base
mitot
capabl
proliferationmitot
pool
compos
myeloblast
progranulocyt
myelocyt
b
storagematur
pool
cell
divis
compos
metamyelocyt
band
segment
neutrophil
iii
marrow
transit
time
myeloblast
releas
segment
neutrophil
day
see
box
neutropenia
character
neutrophil
count
lower
limit
refer
rang
dog
cat
mahaffey
ii
common
dog
cat
often
accompani
leukopenia
iii
neutropenia
accompani
anemia
thrombocytopenia
indic
pancytopenia
suggest
bone
marrow
injuri
effac
gener
mechan
neutropenia
consist
decreas
bone
marrow
product
tissu
util
exceed
marrow
product
releas
box
ii
neutropenia
secondari
increas
margin
sequestr
hemophagocyt
syndrom
immunemedi
damag
circul
neutrophil
granulocyt
precursor
bone
marrow
iii
neutropenia
neg
prognost
indic
associ
increas
mortal
sever
neutropenia
greater
risk
infect
aroch
et
al
iv
neutropenia
result
tissu
util
excess
marrow
product
occur
sever
local
bacteri
infect
involv
bodi
caviti
uteru
respiratori
gastrointestin
gi
tract
gener
septicemia
v
neutropenia
associ
neutrophil
toxic
vi
marrow
suppress
result
decreas
leukocyt
product
may
aris
follow
total
bodi
ioniz
radiat
b
myelosuppress
chemotherapeut
agent
see
chapter
exampl
includ
cyclophosphamid
daunomycin
dimethyl
myleran
doxorubicin
azathioprin
cisplatin
carboplatin
chlorambucil
melphalan
methotrex
mitoxantron
combin
therapi
vincristin
lasparaginas
marrow
neutrophil
proliferationmitot
pool
sensit
chemotherapeut
differenti
cell
maturationstorag
pool
unaffect
releas
matur
neutrophil
continu
day
b
neutropen
nadir
often
occur
day
result
decreas
marrow
product
short
lifespan
circul
neutrophil
chemotherapyinduc
thrombocytopenia
occur
week
circul
lifespan
platelet
day
anemia
uncommon
c
estrogen
toxicosi
dog
sourc
estrogen
exposur
includ
follow
diethylstilbestrol
estradiol
cyclopentylpropion
therapi
use
mismat
urinari
incontin
infertil
femal
may
caus
b
exogen
estrogen
therapi
perian
gland
tumor
male
pancytopenia
occur
neutropenia
c
excess
endogen
estrogen
interstiti
sertoli
cell
tumor
male
granulosa
cell
tumor
femal
also
associ
pancytopenia
sequenti
hematolog
abnorm
canin
estrogen
toxicosi
consist
follow
immedi
leukocytosi
follow
rapid
leukopenia
b
thrombocytosi
follow
rapid
thrombocytopenia
c
slow
develop
anemia
pancytopenia
within
month
prolong
hematolog
fi
nding
consist
cytopenia
involv
two
hematolog
cell
line
circul
fragment
erythrocyt
b
bone
marrow
aspir
reveal
increas
number
macrophag
contain
phagocyt
hematopoiet
precursor
predominantli
erythroid
precursor
fewer
neutrophil
platelet
x
uncommon
caus
neutropenia
includ
follow
immunemedi
neutropenia
idiopath
drugrel
associ
immunemedi
diseas
eg
rheumatoid
arthriti
system
lupu
erythematosu
presumpt
diagnosi
made
clinic
respons
immunosuppress
dose
corticosteroid
termin
therapi
case
drugrel
neutropenia
defi
nitiv
diagnosi
requir
demonstr
antineutrophil
antibodi
diffi
cult
owe
fragil
neutrophil
potenti
releas
intracellular
enzym
b
canin
cyclic
hematopoiesi
genet
disord
specifi
c
graycoat
colli
character
continu
abnorm
cycl
neutropenia
consid
discontinu
delay
chemotherapi
anim
neutrophil
count
start
prophylact
broadspectrum
antibiot
predispos
sepsi
kociba
ii
lithium
carbon
mgkg
po
bid
week
may
revers
marrow
hypoplasia
pancytopenia
secondari
estrogen
toxicosi
dog
hall
iii
lithium
carbon
mgkgday
po
may
partial
allevi
neutropenia
canin
cyclic
hematopoiesi
toxic
effect
latter
dose
campbel
iv
recombin
human
granulocyt
colonystimul
factor
gcsf
mgkgday
sc
day
use
shortterm
manag
neutropenia
dog
cat
neutral
antibodi
develop
cat
dog
within
day
respect
therefor
longterm
use
recommend
ogilvi
phillip
et
al
v
parenter
administr
mg
cobalamin
monthli
result
temporari
remiss
improv
occur
oral
therapi
fyfe
vi
bone
marrow
transplant
lentivirusmedi
gcsf
therapi
use
experiment
treat
lessen
sever
canin
cyclic
hematopoiesi
lothrop
et
al
yanay
et
al
prognosi
recoveri
neutropenia
depend
caus
revers
bone
marrow
damag
ii
neutrophil
count
usual
rebound
chemotherapeut
agent
discontinu
iii
recoveri
follow
estrogen
toxicosi
possibl
variabl
recoveri
may
occur
within
month
b
pancytopenia
may
perman
case
iv
neutropenia
associ
idiosyncrat
drug
reaction
may
resolv
within
week
therapi
discontinu
v
neutropenia
induc
infecti
diseas
carri
fair
felv
good
ehrlichiosi
prognosi
vi
neutropenia
associ
bone
marrow
necrosi
myelophthis
diseas
guard
prognosi
recoveri
possibl
success
treatment
certain
underli
caus
lymphoma
see
box
see
box
see
box
see
box
mast
cell
rare
seen
peripher
blood
smear
occur
certain
condit
mast
cell
seen
peripher
blood
smear
underli
diseas
identifi
ed
treat
ii
see
chapter
discuss
treatment
mastocytosi
neutrophil
suppli
releas
bone
marrow
exce
migrat
neutrophil
site
infl
ammat
ii
end
result
increas
circul
matur
immatur
neutrophil
wbc
count
normal
decreas
excess
number
immatur
rel
matur
neutrophil
often
seen
septicemia
endotoxemia
prognosi
poor
tissu
demand
greater
neutrophil
product
bone
marrow
ii
neutrophil
respons
vari
infl
ammat
peracut
infl
ammat
transient
neutropenia
develop
within
hour
often
respons
endotoxemia
sever
infect
particularli
involv
peritoneum
lung
thorax
b
acut
infl
ammat
bone
marrow
respond
within
hour
increas
tissu
demand
caus
acceler
releas
neutrophil
matur
immatur
result
infl
ammatori
leukogram
character
leukocytosi
neutrophilia
regen
left
shift
gener
immatur
neutrophil
precursorsml
dog
cat
schultz
cowel
decker
c
chronic
prolong
day
week
infl
ammat
character
leukocytosi
matur
neutrophilia
result
expand
marrow
product
exce
tissu
demand
character
leukocytosi
matur
neutrophilia
lymphopenia
eosinopenia
ii
concurr
monocytosi
common
dog
infrequ
cat
iii
accompani
increas
endogen
corticosteroid
concentr
sever
stress
hyperadrenocortic
exogen
glucocorticoid
acth
administr
wbc
count
schultz
b
neutrophilia
absenc
left
shift
c
lymphocyt
count
latim
prass
ii
stress
leukogram
also
occur
concurr
infl
ammatori
leukogram
see
infl
ammatori
leukocytosi
pronounc
leukocytosi
dramat
neutrophilia
dog
cat
signifi
cant
orderli
left
shift
kociba
differenti
chronic
myelogen
leukemia
cml
ii
condit
neutrophil
leukocytosi
left
shift
nonregen
anemia
increas
myeloid
erythroid
ratio
orderli
granulocyt
matur
bone
marrow
iii
suspect
cml
disorderli
left
shift
neutrophil
dysplasia
thrombocytopenia
decreas
marrow
megakaryocyt
granulopoiet
precursor
extramedullari
site
liver
spleen
lymph
node
iv
neutrophil
toxic
indic
infl
ammatori
condit
drug
toxic
system
diseas
typic
featur
cml
transient
leukocytosi
epinephrin
releas
excit
fear
exercis
character
matur
neutrophilia
lymphocytosi
ii
common
puppi
kitten
iii
uncommon
adult
dog
iv
rapid
neutrophilia
neutrophil
count
cat
latim
prass
gener
diminish
within
minut
b
neutrophilia
often
accompani
lymphocytosi
absolut
lymphocyt
count
usual
young
cat
cowel
decker
caus
pathophysiolog
neutrophilia
result
cellular
shift
margin
circul
pool
b
greater
magnitud
cat
larger
margin
pool
ii
lymphocytosi
decreas
migrat
lymphoid
tissu
increas
mobil
thorac
duct
iii
monocyt
eosinophil
number
unchang
slightli
increas
see
tabl
autosom
recess
genet
disord
character
multipl
organ
failur
tabl
ii
intracellular
accumul
incomplet
degrad
substrat
defi
cienci
lysosom
enzym
requir
metabol
diagnosi
examin
peripher
blood
smear
may
reveal
vacuol
abnorm
granul
within
leukocyt
ii
radiographi
help
character
boni
malform
anim
clinic
evid
skelet
abnorm
iii
identifi
cation
defi
cient
lysosom
enzym
activ
plasma
leukocyt
cultur
skin
fi
broblast
attempt
iv
structur
lysosom
enzym
highli
conserv
therefor
techniqu
develop
detect
enzymat
defi
cienci
human
use
dog
cat
v
polymeras
chain
reaction
pcr
base
genom
screen
use
identifi
case
exampl
includ
dog
fucosidosi
mucopolysaccharidosi
mp
mp
vii
cat
mp
vi
b
novel
genet
mutat
occur
diseas
may
detect
establish
test
procedur
therefor
neg
result
elimin
storag
diseas
skelli
franklin
vi
excess
urinari
glycosaminoglycan
excret
anim
mp
detect
urin
spot
test
storag
diseas
gener
untreat
progress
ii
bone
marrow
transplant
result
clinic
improv
dog
mp
cat
mp
vi
see
chapter
acut
lymphoblast
leukemia
character
progress
lymphoblast
infi
ltration
lymphoid
organ
bone
marrow
ii
unlik
lymphoma
bone
marrow
primari
tumor
site
affect
anim
present
nonspecifi
c
sign
anorexia
lethargi
weight
loss
vomit
diarrhea
lame
alter
mentat
intermitt
fever
ii
physic
examin
fi
nding
consist
pallor
hepatosplenomegali
lymphadenopathi
petechia
lymphocytosi
circul
lymphoblast
ii
anemia
thrombocytopenia
variabl
wbc
count
pancytopenia
iii
possibl
absenc
aleukemia
small
number
subleukemia
circul
lymphoblast
iv
possibl
bone
marrow
aspir
andor
biopsi
fi
nding
homogen
popul
larg
immatur
lymphocyt
b
replac
normal
nucleat
cell
popul
lymphoblast
v
possibl
clinic
chemistri
abnorm
increas
alanin
aspart
transferas
alt
ast
alkalin
phosphatas
alp
activ
indic
potenti
liver
involv
b
increas
blood
urea
nitrogen
concentr
indic
azotemia
preren
renal
gi
hemorrhag
c
hypercalcemia
uncommon
diffi
cult
differenti
multicentr
lymphoma
bone
marrow
blood
involv
stage
v
diseas
ii
unlik
advanc
lymphoma
often
occur
without
lymphadenopathi
poorli
respons
chemotherapi
rapid
progress
diseas
cours
iii
differenti
acut
myeloprolif
diseas
see
chapter
requir
cytochem
immunohistochem
stain
bone
marrow
prepar
iv
lymphocytosi
matur
welldifferenti
lymphocyt
distinguish
chronic
lymphocyt
leukemia
cll
see
treat
use
establish
protocol
treatment
canin
felin
lymphoma
fan
couto
use
vincristin
lasparaginas
therapi
togeth
may
result
neutropenia
b
prognosi
poor
treatmentinduc
remiss
short
surviv
gener
less
month
ii
initi
broadspectrum
antibiot
therapi
anim
fever
neutropenia
iii
anim
anemia
andor
thrombocytopenia
consid
fresh
whole
blood
pack
rbc
plateletrich
plasma
platelet
concentr
transfus
see
chapter
chronic
lymphocyt
leukemia
cll
character
lymphocyt
leukocytosi
predomin
small
lymphocyt
ii
report
associ
cll
felv
infect
cat
iii
case
cll
dog
tcell
origin
iv
cll
rare
cat
lgl
leukemia
cat
uncommon
may
accompani
lymphoma
involv
alimentari
tract
mesenter
lymph
node
b
dog
lgl
leukemia
present
either
cll
iii
acut
lymphoblast
leukemia
iv
multicentr
lymphoma
treatment
monitor
treatment
cll
often
requir
especi
absenc
bone
marrow
involv
hematolog
abnorm
anemia
cytopenia
evid
multiorgan
involv
lymphadenopathi
splenomegali
enzym
abnorm
ii
chemotherapi
recommend
develop
clinic
sign
cytopenia
mark
lymphocytosi
gener
defi
ned
iii
combin
protocol
oral
chlorambucil
prednison
effect
dog
cat
workman
vernau
treatment
dog
involv
follow
chlorambucil
mgkg
mgm
po
sid
day
mgkg
mgm
po
sid
longterm
mainten
mgm
qod
prednison
mgm
po
sid
day
follow
mgm
day
mgm
qod
b
treatment
cat
involv
follow
chlorambucil
mgkg
mgcat
qod
prednison
mgkg
sid
c
dosag
modifi
ed
base
clinic
respons
monitor
cbc
weekli
fi
rst
month
monthli
thereaft
e
prognosi
variabl
depend
extent
diseas
respons
therapi
lymphoprolif
diseas
dog
uncommon
cat
rare
ii
character
cutan
lymphoma
circul
popul
larg
neoplast
lymphocyt
intens
cleav
indent
nuclei
promin
nucleoli
ulcer
dermat
pruritu
anorexia
alopecia
peripher
lymphadenopathi
ii
hematolog
abnorm
lymphocyt
leukocytosi
abnorm
lymphocyt
morpholog
b
possibl
monocytosi
neutrophilia
nonregen
normocyt
normochrom
anemia
dermalepiderm
infi
ltration
neoplast
lymphocyt
skin
biopsi
sampl
combin
presenc
circul
neoplast
lymphocyt
chemotherapeut
protocol
canin
lymphoma
tri
ii
prognosi
poor
